← Back to Clinical Trials
Recruiting NCT06824623

NCT06824623 Readmission and Dehydration Prevention in Patients With Elective Ileostomy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06824623
Status Recruiting
Phase
Sponsor Multidisciplinary Italian Study group for STOmas (MISSTO)
Condition Ileostomy - Stoma
Study Type OBSERVATIONAL
Enrollment 300 participants
Start Date 2025-06-01
Primary Completion 2026-05-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 300 participants in total. It began in 2025-06-01 with a primary completion date of 2026-05-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this prospective observational study is to evaluate the adherence to DRIP score calculation and the application rate of each proposed item to prevent dehydration and readmission in patients undergoing ileostomy creation after elective colorectal resection different Italian colorectal surgical centers. The primary endpoint is to verifythe application rate of DRIP score calculation and protocol items. Secondary endpoints are 30, 90, and 180-day total and dehydration readmission rates.

Eligibility Criteria

Inclusion Criteria: * All patients with elective ileostomy performed during the study period for benign or malignant colorectal disease * Age \> 18 years * Written consent Exclusion Criteria: * Emergency surgery * Other ostomy than ileostomy

Contact & Investigator

Central Contact

Francesco Ferrara, MD

✉ frr.fra@gmail.com

📞 +393343035829

Principal Investigator

Francesco Ferrara, MD

PRINCIPAL INVESTIGATOR

Multidisciplinary Italian Study group for STOmas (MISSTO)

Frequently Asked Questions

Who can join the NCT06824623 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Ileostomy - Stoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06824623 currently recruiting?

Yes, NCT06824623 is actively recruiting participants. Contact the research team at frr.fra@gmail.com for enrollment information.

Where is the NCT06824623 trial being conducted?

This trial is being conducted at Legnano, Italy, Milan, Italy, Monza, Italy, Palermo, Italy and 3 additional locations.

Who is sponsoring the NCT06824623 clinical trial?

NCT06824623 is sponsored by Multidisciplinary Italian Study group for STOmas (MISSTO). The principal investigator is Francesco Ferrara, MD at Multidisciplinary Italian Study group for STOmas (MISSTO). The trial plans to enroll 300 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology